Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Oppenheimer boosted the price target for Tarsus Pharmaceuticals, Inc. TARS from $55 to $59. Oppenheimer analyst Francois Brisebois reiterated an Outperform rating. Tarsus Pharmaceuticals shares gained 18.3% to close at $39.22 on Tuesday. See how other analysts view this stock.
- Wedbush increased the price target for Apellis Pharmaceuticals, Inc. APLS from $60 to $67. Wedbush analyst Laura Chico maintained a Neutral rating. Apellis Pharmaceuticals shares fell 3.3% to close at $69.35 on Tuesday. See how other analysts view this stock.
- Needham increased Axon Enterprise, Inc. AXON price target from $240 to $315. Needham analyst Joshua Reilly maintained a Buy rating. Axon Enterprise shares rose 0.1% to close at $271.82 on Tuesday. See how other analysts view this stock.
- Mizuho slashed the price target for Essex Property Trust, Inc. ESS from $255 to $250. Mizuho analyst Vikram Malhorta upgraded the stock from Neutral to Buy. Essex Property Trust shares gained 0.9% to close at $227.73 on Tuesday. See how other analysts view this stock.
- Raymond James lowered Integral Ad Science Holding Corp. IAS price target from $20 to $16. Raymond James analyst Andrew Marok downgraded the stock from Strong Buy to Outperform. Integral Ad Science shares gained 1.4% to close at $17.10 on Tuesday. See how other analysts view this stock.
- DA Davidson boosted the price target for Sterling Infrastructure, Inc. STRL from $86 to $115. DA Davidson analyst Brent Thielman downgraded the stock from Buy to Neutral. Sterling Infrastructure shares climbed 18.1% to close at $106.22 on Tuesday. See how other analysts view this stock.
- Needham boosted LendingTree, Inc. TREE price target from $17 to $40. Needham analyst Mayank Tandon maintained a Buy rating. LendingTree shares fell 4.8% to close at $32.62 on Tuesday. See how other analysts view this stock.
- Keybanc boosted ICU Medical, Inc. ICUI price target from $134 to $136. Keybanc analyst Brett Fishbin maintained an Overweight rating. ICU Medical shares climbed 1.2% to close at $106.81 on Tuesday. See how other analysts view this stock.
- Barclays raised Ecolab Inc. ECL price target from $225 to $260. Barclays analyst Manav Patnaik upgraded the stock from Equal-Weight to Overweight. Ecolab shares gained 0.8% to close at $222.09 on Tuesday. See how other analysts view this stock.
- Telsey Advisory Group increased Abercrombie & Fitch Co. ANF price target from $105 to $140. Telsey Advisory Group maintained an Outperform rating. Abercrombie & Fitch shares fell 0.3% to close at $125.78 on Tuesday. See how other analysts view this stock.
Check This Out: These 3 Energy Stocks With Over 5% Dividend Yields Are Recommended By Wall Street's Most Accurate Analysts
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in